- Investing Ideas
- Global Pharmaceuticals & Biotech Breakout Stocks
Global Pharmaceuticals & Biotech Breakout Stocks
Results
66
Stocks where the price continues to rise after more than a year of consistent gains.
66 companies
Insmed
Market Cap: US$29.4b
Develops and commercializes therapies for patients with serious and rare diseases in the United States, Europe, Japan, and internationally.
INSM
US$132.57
7D
34.2%
1Y
8.7%
Charles River Laboratories International
Market Cap: US$13.2b
Charles River Laboratories International, Inc.
CRL
US$282.00
7D
20.5%
1Y
84.6%
Halozyme Therapeutics
Market Cap: US$11.6b
A biopharmaceutical company, researches, develops, and commercializes of proprietary enzymes and devices in the United States, Switzerland, Belgium, Japan, and internationally.
HALO
US$102.62
7D
23.3%
1Y
60.2%
Twist Bioscience
Market Cap: US$7.8b
Manufactures and sells synthetic DNA-based products.
TWST
US$123.12
7D
23.8%
1Y
348.5%
10x Genomics
Market Cap: US$7.6b
Develops and sells instruments, consumables, and software for analyzing biological systems in the United States, rest of the Americas, Europe, the Middle East, Africa, China, and the rest of the Asia Pacific.
TXG
US$58.48
7D
22.2%
1Y
356.5%
Genscript Biotech
Market Cap: HK$54.4b
An investment holding company, engages in the manufacture and sale of life science research products and services in the United States of America, Europe, Mainland China, Europe, Asia Pacific, and internationally.
1548
HK$24.86
7D
32.6%
1Y
40.6%
Harbin Pharmaceutical Group
Market Cap: CN¥22.2b
Engages in the research, development, manufacture, wholesale, and retail of pharmaceuticals in China and internationally.
600664
CN¥8.81
7D
30.1%
1Y
121.4%
Iovance Biotherapeutics
Market Cap: US$2.9b
A commercial-stage biopharmaceutical company, develops and commercializes cell therapies using autologous tumor infiltrating lymphocyte for the treatment of metastatic melanoma and other solid tumor cancers in the United States and internationally.
IOVA
US$6.49
7D
48.9%
1Y
191.0%
AbCellera Biologics
Market Cap: US$2.9b
Engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States.
ABCL
US$9.76
7D
60.3%
1Y
128.6%
GemPharmatech
Market Cap: CN¥15.8b
A contract research organization, provides genetically engineered mouse models and preclinical research services to the scientific community worldwide.
688046
CN¥38.60
7D
41.6%
1Y
115.6%
HitGen
Market Cap: CN¥15.2b
Operates as a drug discovery research platform for small molecules and nucleic acid drugs in China and internationally.
688222
CN¥37.90
7D
22.9%
1Y
67.0%
Sino BiologicalInc
Market Cap: CN¥14.1b
Engages in the provision of recombinant protein and antibody reagents for life science researchers in China and internationally.
301047
CN¥116.30
7D
28.4%
1Y
58.5%
Shanghai Medicilon
Market Cap: CN¥13.9b
A contract research organization, provides drug discovery and development services to pharmaceutical and biotechnology companies in China and internationally.
688202
CN¥106.00
7D
33.9%
1Y
65.3%
AcrobiosystemsLtd
Market Cap: CN¥13.7b
Engages in the development and manufacture of recombinant proteins, antibodies, and other biological reagents for pharmaceutical and biotechnology companies, and research institutions.
301080
CN¥82.20
7D
52.3%
1Y
43.9%
Septerna
Market Cap: US$1.8b
A clinical-stage biotechnology company, discovers and develops G protein-coupled receptor (GPCR) oral small molecule products for the treatment of endocrinology, immunology and inflammation, and metabolic diseases.
SEPN
US$47.76
7D
22.5%
1Y
326.4%
PharmaBlock Sciences (Nanjing)
Market Cap: CN¥11.5b
Provides chemistry products and services throughout the pharmaceutical research and development, and commercial manufacturing in China and internationally.
300725
CN¥49.52
7D
21.2%
1Y
3.5%
HARBIN GLORIA PHARMACEUTICALS
Market Cap: CN¥8.6b
Engages in the research, development, production, and sale of pharmaceutical products in the People’s Republic of China and internationally.
002437
CN¥3.86
7D
32.2%
1Y
6.6%
PharmaResources (Shanghai)
Market Cap: CN¥7.1b
Operates as a one-stop integrated service provider for new drug research, development, and commercial manufacturing to pharmaceutical and biotechnology companies in China and internationally.
301230
CN¥39.60
7D
45.0%
1Y
37.6%
Bide Pharmatech
Market Cap: CN¥6.9b
Engages in the research, development, production, and sale of drug molecule building blocks and scientific reagents in China.
688073
CN¥79.60
7D
54.7%
1Y
35.0%
Anhui Wanbang Pharmaceutical TechnologyLtd
Market Cap: CN¥6.9b
Anhui Wanbang Pharmaceutical Technology Co.,Ltd.
301520
CN¥73.90
7D
50.1%
1Y
119.7%
Geron
Market Cap: US$950.9m
A commercial-stage biopharmaceutical company, focuses on the development of therapeutics products for oncology.
GERN
US$1.63
7D
21.6%
1Y
20.7%
GlaxoSmithKlineE
Market Cap: ج.م45.9b
Engages in production of pharmaceutical chemicals.
BIOC
ج.م550.00
7D
32.8%
1Y
1,068.2%
R&G PharmaStudies
Market Cap: CN¥6.1b
Operates as a clinical trial outsourcing service provider in China and internationally.
301333
CN¥63.96
7D
24.7%
1Y
13.5%
Aarti Pharmalabs
Market Cap: ₹80.6b
Manufactures and sells active pharmaceutical ingredients, pharmaceutical intermediates, and xanthine derivatives in India and internationally.
AARTIPHARM
₹888.70
7D
30.1%
1Y
12.4%
Xinjiang Bai Hua Cun Pharma TechLtd
Market Cap: CN¥5.4b
Engages in pharmaceutical research and development, clinical trials, biomedicine, commercial properties, and other businesses.
600721
CN¥14.03
7D
61.1%
1Y
73.9%
Immix Biopharma
Market Cap: US$724.7m
A clinical-stage biopharmaceutical company, engages in the development of chimeric antigen receptor cell therapy in light chain Amyloidosis and immune-mediated diseases in the United States and Australia.
IMMX
US$11.49
7D
23.2%
1Y
399.6%
Silence Therapeutics
Market Cap: US$693.1m
A biotechnology company, engages in the discovery and development of novel molecules incorporating short interfering ribonucleic acid (siRNA) to inhibit the expression of specific target genes in hematology, cardiovascular, and rare diseases.
SLN
US$14.72
7D
31.0%
1Y
151.6%
Boji Medical TechnologyLtd
Market Cap: CN¥4.6b
Provides professional contract research services for research and development, and production of drugs and medical devices to pharmaceutical enterprises in China and internationally.
300404
CN¥12.04
7D
21.5%
1Y
7.5%
Novoprotein Scientific
Market Cap: CN¥3.7b
Researches, develops, produces, and sells raw materials and technical solutions for bio-pharmaceutical enterprises and research institutions in Asia, Europe, the United States, and Oceania.
688137
CN¥53.33
7D
34.6%
1Y
13.5%
Shanghai Kai Kai Industry
Market Cap: CN¥3.4b
Engages in the wholesale and retail of pharmaceutical products in China.
600272
CN¥17.27
7D
61.1%
1Y
24.5%
Evolus
Market Cap: US$500.0m
A performance beauty company, delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia.
EOLS
US$8.34
7D
36.3%
1Y
30.3%
OmniAb
Market Cap: US$492.9m
A biotechnology company, licenses discovery research technology to pharmaceutical and biotech companies, and academic institutions to enable the discovery of therapeutics in the United States, Europe, Japan, China, and Canada.
OABI
US$3.38
7D
69.0%
1Y
72.4%
EI- Nile for Pharmaceuticals and Chemical Industries
Market Cap: ج.م23.0b
Develops, produces, and sells pharmaceutical products in Egypt.
NIPH
ج.م460.01
7D
74.9%
1Y
897.9%
Fennec Pharmaceuticals
Market Cap: US$380.0m
Operates as a commercial stage biopharmaceutical company in the United States.
FENC
US$12.78
7D
26.4%
1Y
38.3%
Foghorn Therapeutics
Market Cap: US$370.6m
A clinical-stage biopharmaceutical company, engages in the discovery and development of medicines targeting genetically determined dependencies within the chromatin regulatory system in the United States.
FHTX
US$6.59
7D
35.6%
1Y
35.3%
Kwality Pharmaceuticals
Market Cap: ₹34.4b
Together with its subsidiary, manufactures finished pharmaceutical formulations in India and internationally.
539997
₹3,318.75
7D
29.8%
1Y
207.7%